08
February
0
Comments
VC-Backed Gossamer Bio Begins Trading After $276M IPO
in Legal News
Law360 (February 8, 2019, 4:36 PM EST) — San Diego-based biopharmaceutical company Gossamer Bio started trading on the Nasdaq Global Select Market on Friday after the Latham & Watkins LLP-led company priced a $276 million initial public offering….
